亚太药业：注射用阿昔洛韦通过仿制药一致性评价将进一步丰富公司产品管线

中国财富通2025-04-28

4月28日，亚太药业（002370）公告称，公司于近日收到国家药品监督管理局核准签发的关于注射用阿昔洛韦的《药品补充申请批准通知书》，公司注射用阿昔洛韦通过仿制药质量和疗效一致性评价。公司本次注射用阿昔洛韦通过仿制药质量和疗效一致性评价，将进一步丰富公司的产品管线，有利于提升该药品的市场竞争力，同时为公司后续其他产品开展仿制药一致性评价工作积累经验。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530427549?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-28 17:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2530427549","market":"hk","top_or_hot":-1,"title":"亚太药业：注射用阿昔洛韦通过仿制药一致性评价 将进一步丰富公司产品管线","media":"中国财富通","content":"<html><body><p>4月28日，<a href=\"https://laohu8.com/S/002370\">亚太药业</a>（002370）公告称，公司于近日收到国家药品监督管理局核准签发的关于注射用阿昔洛韦的《药品补充申请批准通知书》，公司注射用阿昔洛韦通过仿制药质量和疗效一致性评价。公司本次注射用阿昔洛韦通过仿制药质量和疗效一致性评价，将进一步丰富公司的产品管线，有利于提升该药品的市场竞争力，同时为公司后续其他产品开展仿制药一致性评价工作积累经验。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>亚太药业：注射用阿昔洛韦通过仿制药一致性评价 将进一步丰富公司产品管线</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n亚太药业：注射用阿昔洛韦通过仿制药一致性评价 将进一步丰富公司产品管线\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-28 17:31 北京时间&nbsp;&nbsp;&nbsp;<a href=https://irb.cfbond.com/api/v1/detail.html?newsid=G%2FLQurIQqIY%3D><strong>中国财富通</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月28日，亚太药业（002370）公告称，公司于近日收到国家药品监督管理局核准签发的关于注射用阿昔洛韦的《药品补充申请批准通知书》，公司注射用阿昔洛韦通过仿制药质量和疗效一致性评价。公司本次注射用阿昔洛韦通过仿制药质量和疗效一致性评价，将进一步丰富公司的产品管线，有利于提升该药品的市场竞争力，同时为公司后续其他产品开展仿制药一致性评价工作积累经验。</p>\n\n<a href=\"https://irb.cfbond.com/api/v1/detail.html?newsid=G%2FLQurIQqIY%3D\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002370","symbol_name":"亚太药业","start_time":0,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=G%2FLQurIQqIY%3D","article_id":"2530427549","we_media_id":"1032789997","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530427549","pubTimestamp":1745832711,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"中国财富通","introduction":"中国财富通：是互联网信息披露服务新工具，它能帮助上市公司和金融机构整合信息披露传播媒介，方便、快捷、自主地披露和推送金融信息，一键触达金融消费者、中小投资者和机构投资者，提升信息披露和传播有效性。","home_visible":1,"id":"1032789997","head_image":"https://static.tigerbbs.com/64b1ce999a7d9c12781c2da3dd08435c"},"summary":"4月28日，亚太药业（002370）公告称，公司于近日收到国家药品监督管理局核准签发的关于注射用阿昔洛韦的《药品补充申请批准通知书》，公司注射用阿昔洛韦通过仿制药质量和疗效一致性评价。公司本次注射用阿昔洛韦通过仿制药质量和疗效一致性评价，将进一步丰富公司的产品管线，有利于提升该药品的市场竞争力，同时为公司后续其他产品开展仿制药一致性评价工作积累经验。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"002370":"亚太药业","BK0132":"高送转概念","BK0239":"医药制造"},"translate_title":"Asia Pacific Pharmaceutical: Acyclovir for injection passes the consistency evaluation of generic drugs and will further enrich the company's product pipeline","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002370":1},"content_text":"4月28日，亚太药业（002370）公告称，公司于近日收到国家药品监督管理局核准签发的关于注射用阿昔洛韦的《药品补充申请批准通知书》，公司注射用阿昔洛韦通过仿制药质量和疗效一致性评价。公司本次注射用阿昔洛韦通过仿制药质量和疗效一致性评价，将进一步丰富公司的产品管线，有利于提升该药品的市场竞争力，同时为公司后续其他产品开展仿制药一致性评价工作积累经验。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530427549","isCrawlerRequest":true}

亚太药业：注射用阿昔洛韦通过仿制药一致性评价 将进一步丰富公司产品管线

精彩评论

亚太药业：注射用阿昔洛韦通过仿制药一致性评价将进一步丰富公司产品管线